- Product Details
Keywords
- Cholesterol
- Vytorin
- Ezetimibe
Quick Details
- ProName: Zetia
- CasNo: 163222-33-1
- Molecular Formula: C24H21F2NO3
- Appearance: white solid
- Application: Oral drinking with cas no 163222-33-1
- DeliveryTime: Express delivery
- PackAge: Descrete packaging with aluminum foil
- Port: Borispol
- ProductionCapacity: Metric Ton/Day
- Purity: 99%
- Storage: room temperature
- Transportation: Air
- LimitNum: 0 Metric Ton
Superiority
Use alone or in combination with a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) as an adjunct to dietary therapy to decrease elevated serum total cholesterol, LDL-cholesterol, and apolipoprotein B (apo B) concentrations in the treatment of primary (heterozygous familial and nonfamilial) hypercholesterolemia.
Effects on cardiovascular morbidity and mortality not established.
Use in fixed combination with simvastatin (i.e., Vytorin) as an adjunct to dietary therapy to decrease elevated serum total cholesterol, LDL-cholesterol, apo B, triglyceride, and non-HDL-cholesterol concentrations, and to increase HDL-cholesterol concentrations in the treatment of primary hypercholesterolemia or mixed dyslipidemia.
Use in combination with fenofibrate as an adjunct to dietary therapy to decrease elevated serum total cholesterol, LDL-cholesterol, apo B, and non-HDL-cholesterol concentrations in the treatment of mixed dyslipidemia.Effects on cardiovascular morbidity and mortality not established. Use with a fibric acid derivative other than fenofibrate not studied and currently not recommended.